KHIDI Spearheads Support For Korea Biopharma Globalization

Bridge Between Govt, Private Sector

Korea Health Industry Development Institute President Soon-Do Cha talks to Scrip how the government agency’s support strategy to the domestic biopharma industry may be changing in line with the industry’s increased globalization move and how he views the country’s policy stance should improve going forward to meet its goal of becoming a strong biohealth nation.

Soon-Do Cha, President Of KHIDI
Korea Should Innovate Regulations In Line With Changing Global Trends, KHIDI Says • Source: KHIDI

As South Korea seeks to foster the biohealth industry through various strategies including creating new markets, the Korea Health Industry Development Institute (KHIDI) is also making broad efforts in its role as a state-funded agency at the front line of the intersect between the government and private sector.

With the domestic industry’s globalization entering a more active phase - the number of Korean biopharma firms advancing into overseas...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia